Monday, November 24, 2025 11:55:57 AM
that deal was negotiated between the CEO of Elite and the CEO of Mikah, right?
NO, IT WAS NOT. iT WAS ONLY MIKAH AND SUNGEN. Elite had no dealing with the sale. Why would Elite be involve? As CEO of Eltp, yes he knew what he was doing, but I don't believe it was offered to Elite, no records or written statement had said that, it was hearsay. I only know that a sale between Mikah and Sungen to sell their half which came out to be 50% of Adderall. As the Ceo of Elite and owner of Mikah, Hakim Nasrat knew or both parties knew, the saying that Elite had no way of buying the other 50% is questionable.
I say its questionable or a gray area because there are no written documents and therefore you can say anything or make up any excuse. I'm just laying what I found over the internet and wondering if its true or not.
Is there a fairness opinion somewhere?
Well, this is the point of having ownership of a company in this case Mikah, and being the CEO of ELTP, and are doing business together, against one another, is this legal? that's the issue.
NO, IT WAS NOT. iT WAS ONLY MIKAH AND SUNGEN. Elite had no dealing with the sale. Why would Elite be involve? As CEO of Eltp, yes he knew what he was doing, but I don't believe it was offered to Elite, no records or written statement had said that, it was hearsay. I only know that a sale between Mikah and Sungen to sell their half which came out to be 50% of Adderall. As the Ceo of Elite and owner of Mikah, Hakim Nasrat knew or both parties knew, the saying that Elite had no way of buying the other 50% is questionable.
I say its questionable or a gray area because there are no written documents and therefore you can say anything or make up any excuse. I'm just laying what I found over the internet and wondering if its true or not.
Is there a fairness opinion somewhere?
Well, this is the point of having ownership of a company in this case Mikah, and being the CEO of ELTP, and are doing business together, against one another, is this legal? that's the issue.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
